@xiaoeh, all glove counters are turning around. From negative earnings to positive earnings. Karex is following the gloves stocks. The 1st quarter results will be released next Monday. Expected target price is RM0.72.
Still manage to turn from -0.005 to +0.010 and closed at RM0.705. The AGM and 1st quarter results are on next Monday (27 Nov 2023). The target price still maintains at RM0.72.
By the end of the first half of the financial year 2024 (28 Feb 2024), the FDA (Food and Drug Administration) of US should have approved the new 001 condoms to be exported to US. The price of Karex will move north.
I went in today (2 Feb 2024). There is nothing much that I could do now. Just wait until end of February to see whether its quarter results is good enough or not. Bears are in full control now.
The long tail below the body is indicative of sellers trying to push the price down by a significant amount but the buyers manage to push it back up. The buyers do this to show a definitive buying strength which will lead to an increase in price, going forward.
KAREX is riding on the strong growth in the condom industry, focusing on high-margin products which will take its profitability to a higher level. It is penetrating high-growth markets with premium offerings backed by innovation and strict compliance with international standards. We project its earnings to double in FY24, followed by another 88% surge in FY25. We initial coverage on KAREX with an OUTPERFORM rating and a TP of RM1.00.
Read and listen to the words from Karex CEO. "Karex pivots beyond latex condoms". Results have been better quarter over quarter for 5 consecutive quarters. He said 26 Feb 2024 will also be better than the previous quarter. New products are lubricant and gloves.
Please understand that RM0.87 at this moment is not Karex all time high. Its all time high was RM3.10 on 11.3.2016. It is unlike Sunway, MBMR, HUMEIND, etc.
The heyday of being the sole and top condom manufacturer in Malaysia is over for Karex Bhd. I used to own a significant number of Karex shares, but it saddens me that the management has failed to turn the company around even after many years. I don't believe Karex will recover to its previous highs
Agree with Kenanga's analyst with regards to the emphasis on improving margins by the company. However, the focus on premium products is not really feasible cause condom users do not place much importance on the actual quality of the products compared to other consumer staples. There is no way for the company to bring the sales volume/total sales back to 2016 levels because the competition within the condom market is surging. Despite the recent introduction of abortion laws in the US, there isn't any significant uptick in sales for the US market which is a bit disappointing.
However, there still remains a few tailwinds for the condom market and near-term catalysts for Karex. Such as weaker Ringgit, and the stabilisation of raw material/labour cost. And the diversification/venture into gloves and lubricant products, on top of the company's healthy balance sheet.
Consolidation shall finished.. $1.06 kenanga target coming.. KAREX is the largest condom Mfg in the world.. It need to reflect its strength but not below $1 penny world class
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Vhydro
1,553 posts
Posted by Vhydro > 2023-11-15 21:56 | Report Abuse
ChloeTai, you got support Karex by buying condom to use onot?